1-4 of 4
María Teresa Artola, MD
Close
Sort by
Journal Articles

Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups

Josep-Maria Ribera, Mireia Morgades, M.Prob.S, Rosa Coll, MD, Jose Luis Lopez Lorenzo, MD, Pau Montesinos, MD PhD, Rosario Varela, Mónica Cabrero, Ignacio Gómez-Centurión, M. Dolores Morales, MD, Antoni Garcia-Guiñon, MD, Guiomar Bautista, Pilar Herrera Puente, Laura Llorente, Irene García-Cadenas, Pere Barba, MD PhD, Maria Calbacho, MD, Cristina Gil, Maria Angeles Foncillas, María Teresa Artola, MD, Rafael De La Camara, MD, Jose Luis Piñana Sanchez
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-134296
Published: 2020
Journal Articles

Outcome of Adults with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) Included in Minimal Residual Disease (MRD)-Oriented Trials

Josep-Maria Ribera, Eduardo Cerello Chapchap, MD, Mireia Morgades, M.Prob.S, Eulàlia Genescà, PhD, Cristina Gil, Irene García-Cadenas, Pere Barba, MD PhD, José González-Campos, MD, Anna Torrent, Teresa Bernal del Castillo, MD PhD, Maria Paz Queipo De Llano, MD, María-Luz Amigo, MD, Mar Tormo, MD, Rosa Coll, MD, Ferran Vall-Llovera, MD, Jordi Ribera, PhD, Maria Jose Sanchez, MD, Beatriz Soria, MD, Antonia Cladera, María Teresa Artola, MD, Antoni Garcia-Guiñon, MD, Alberto Giménez Conca, MD, Lourdes Amador Barciela, MD, Juana Ciudad, PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-137383
Published: 2020
Journal Articles

Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) in Adult Patients with High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Acute Lymphoblastic Leukemia (ALL) According to Their Minimal Residual Disease (MRD). Final Results of the Pethema ALL-HR-11 Trial

Josep-Maria Ribera, MD PhD, Mireia Morgades, M.Prob.S, Juana Ciudad, PhD, Pau Montesinos, MD PhD, Pere Barba, MD PhD, Irene García-Cadenas, María José Moreno, MD, Susana Vives, MD, Jordi Esteve, Cristina Gil, Silvia Monsalvo, MD, María Teresa Artola, MD, Jordi Ribera, PhD, Eulàlia Genescà, PhD, Mar Tormo, MD PhD, Marta Cervera, MD, Daniel Martínez-Carballeira, MD, Andrés Novo, MD, José González-Campos, MD, Beatriz Soria, MD, Arancha Bermúdez, MD, Aurelio López Martínez, MD, Santiago Mercadal, MD, Rosa Fernández-Martín, MD, Rosa Coll, MD, Josefina Serrano, Maria Luz Amigo, MD, Pilar Martínez-Sánchez, Juan-Miguel Bergua, MD, Alfons Serrano-Maestro, MD, Alberto Giménez Conca, MD, Susana Barrena, PhD, Isabel Granada, PhD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 826.
https://doi.org/10.1182/blood-2019-123613
Published: 2019
Journal Articles

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Eulalia Genesca, PhD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Pere Barba, MD, Cristina Gil, MD PhD, Ramon Guàrdia, MD, Maria Jose Moreno, MD, Daniel Martínez-Carballeira, MD, Irene García-Cadenas, Susana Vives, MD, Jordi Ribera, José González-Campos, MD, Marina Diaz-Beyá, MD, Santiago Mercadal, MD, Maria Teresa Artola, MD, Antonia Cladera, MD, Mar Tormo, MD PhD, Arancha Bermudez, MD, Ferran Vall-Llovera, MD, Pilar Martinez, MD, María-Luz Amigo, MD, Juan-Miguel Bergua, MD, María Calbacho, MD, Jesús-María Hernández-Rivas, MD PhD, Silvia Monsalvo, Andrés Novo, MD, Marta Cervera, MD, Antonio Garcia-Guiñon, MD, Jordi Junca, MD, Juana Ciudad, PhD, Alberto Orfao, MD PhD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1553.
https://doi.org/10.1182/blood-2018-99-114559
Published: 2018